LEVOCARNITINE INJECTION DIN 02562685
Health Canada record
| Active ingredient(s) | LEVOCARNITINE 200 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | A16AA01 LEVOCARNITINE |
| Original market date | |
| Current status date | 24-Nov-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
SOLA Pharmaceuticals Canada LP — licence 3-002683, currently licensed, last inspection rating C (2023-05-03).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing LEVOCARNITINE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02144328 | CARNITOR | LEADIANT BIOSCIENCES, INC | Tablet | LEVOCARNITINE 330 MG | Marketed |
| 02144336 | CARNITOR | LEADIANT BIOSCIENCES, INC | Solution | LEVOCARNITINE 100 MG | Marketed |
| 02144344 | CARNITOR | LEADIANT BIOSCIENCES, INC | Solution | LEVOCARNITINE 200 MG | Marketed |
| 02566958 | LEVOCARNITINE INJECTION | JUNO PHARMA CANADA INC. | Solution | LEVOCARNITINE 200 MG | Approved |
| 02492105 | ODAN LEVOCARNITINE | ODAN LABORATORIESLTD | Solution | LEVOCARNITINE 100 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 36421 | 2025-11-20 | Abbreviated New Drug Submission (ANDS) |
International API supply for LEVOCARNITINE
4 valid EDQM Certificates of Suitability from 4 holders. 9 active FDA Drug Master Files.
Request a quote for LEVOCARNITINE INJECTION